Yong‐Long Liu

Isolation of Potential Cancer Chemopreventive Agents from Eriodictyon californicum

Yong‐Long Liu, David K. Ho, John M. Cassady et al. · Journal of Natural Products · 1992 · 151 citations

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Rui You, You‐Ping Liu, Yu‐Long Xie et al. · The Lancet · 2023 · 100 citations

Adaptive Radiotherapy, Standard Fractionation, Surgical Oncology +9

Swertifrancheside, an HIV-Reverse Transcriptase Inhibitor and the First Flavone-Xanthone Dimer, from Swertia franchetiana

Jiannong Wang, Cui-Ying Hou, Yong‐Long Liu et al. · Journal of Natural Products · 1994 · 66 citations

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study

Xi Ding, Weijing Zhang, Rui You et al. · Journal of Clinical Oncology · 2023 · 64 citations · Full text

Flavonoids from Artemisia frigida

Yong‐Long Liu, Tom J. Mabry · Phytochemistry · 1981 · 56 citations

Bioorganic Chemistry, Botany, Natural Sciences +4